Dr. Lillian Siu is a staff Medical Oncologist at Princess Margaret Hospital since 1998, and is a professor at the University of Toronto. She is the Director of the Phase I Program and Co-Director of the Robert and Maggie Bras and Family Drug Development Program at Princess Margaret Hospital. Dr. Siu’s major research focus is in the area of new anticancer drug development, particularly with respect to phase I trials and head and neck malignancies. In 2009, she has been awarded a Cancer Care Ontario Chair in Experimental Therapeutics. In addition, she is the principal investigator of the Princess Margaret Hospital Phase I Consortium, supported by a grant from the United States National Cancer Institute. Dr. Siu is the 2009-2010 Chair for ASCO Grants Selection Committee, and the current Neuroendocrine Tumor Task Force Chair in the Gastrointestinal Intergroup Scientific Steering Committee. Dr. Siu has a strong interest in clinical trial methodology and is one of the course directors of the ECCO/ASCO/AACR workshop in Flims, Switzerland. Dr. Siu has published over 100 peer-reviewed manuscripts